Variant prevalence has continually evolved over time during the COVID-19 pandemic. Early in 2022, the omicron variant of SARS-CoV-2 started to take over in the U.S. Week by week, different subvariants from the omicron lineage became more dominant among the genetically sequenced COVID-19 cases in the U.S.